NASDAQ : EQRX

EQRx, Inc. — Institutional Ownership

$2.34 USD

-$0.05 (-2.09%)

Volume
11.93M
Average Volume
4.5M
Market Capitalization
$1.14B
P/E Ratio
5.44
Dividend Yield
0.00%
Price Target
$5.00
Year High
$4.75
Year Low
$1.58
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$27.51
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2023-02-09 The Vanguard Group - 23-1945930 25.95M 5.31%
2022-02-14 Alphabet Holdings LLC 47.25M 9.69%
2022-02-14 GV 2019 GP, L.P. 47.25M 9.69%
2022-02-14 GV 2019 GP, L.L.C. 47.25M 9.69%
2022-02-14 XXVI Holdings Inc. 47.25M 9.69%
2022-02-14 GV 2019, L.P. 47.25M 9.69%
2022-02-14 Alphabet Inc. 47.25M 9.69%
2022-02-11 Robert Nelsen 36.34M 7.50%
2022-02-11 ARCH Venture Fund X Overage, L.P. 36.34M 7.50%
2022-02-11 ARCH Venture Partners X, L.P. 36.34M 7.50%
2022-02-11 ARCH Venture Partners X Overage, L.P. 36.34M 7.50%
2022-02-11 ARCH Venture Fund X, L.P. 36.34M 7.50%
2022-02-11 Kristina Burow 36.34M 7.50%
2022-02-11 ARCH Venture Partners X, LLC 36.34M 7.50%
2022-02-11 Crandell 36.34M 7.50%
2022-02-11 Gillis 36.34M 7.50%
2021-12-27 AH Equity Partners LSV I, L.L.C. (“AH Equity LSV I”) 11.43M 2.30%
2021-12-27 Andreessen Horowitz LSV Fund II, L.P. (“AH LSV II”) 5M 1.00%
2021-12-27 AH Equity Partners LSV II, L.L.C. (“AH Equity LSV II”) 5M 1.00%
2021-12-27 Marc Andreessen (“Andreessen”) 53.06M 10.90%
2021-12-27 Benjamin Horowitz (“Horowitz”) 53.06M 10.90%
2021-12-27 SoftBank Group Corp. 43.98M 9.00%
2021-12-27 Andreessen Horowitz LSV Fund I, L.P. (“AH LSV I”) 11.43M 2.30%
2021-12-27 SB Management Limited 43.98M 9.00%
2021-12-27 AH Bio Fund II, L.P. (“AH Bio II”) 17.44M 3.60%
2021-12-27 AH Equity Partners Bio II, L.L.C. (“AH Equity Bio II”) 17.44M 3.60%
2021-12-27 AH Bio Fund III, L.P. (“AH Bio III”) 19.19M 3.90%
2021-12-27 AH Equity Partners Bio III, L.L.C. (“AH Equity Bio III”) 19.19M 3.90%
2021-12-10 Citadel Advisors Holdings LP 6.0 4.10%
EQRX Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2022-12-31 $2.46 474.3M $1.17B $494.14M $3.83M $676.46M
2021-12-31 $6.82 470M $3.21B $1.68B $3.37M $1.53B
2020-12-31 $10.08 311.5M $3.14B $489.68M $5.08M $2.66B
2019-12-31 $10.08 426.4M $4.3B $18.48M $25.88M $4.31B
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2023-09-30 $2.22 484.23M $1.07B $315.68M $2.06M $761.37M
2023-06-30 $1.86 482.12M $896.74M $247.5M $2.64M $651.89M
2023-03-31 $1.94 480.01M $931.22M $368.36M $3.22M $566.08M
2022-12-31 $2.46 477.84M $1.18B $494.14M $3.83M $685.18M
2022-09-30 $4.95 475.57M $2.35B $998.02M $4.56M $1.36B
2022-06-30 $4.69 473.06M $2.22B $864.44M $5.26M $1.36B
2022-03-31 $4.13 470.63M $1.94B $1.62B $2.63M $323.05M
2021-12-31 $6.82 469.37M $3.2B $1.68B $3.37M $1.53B
2021-09-30 $9.92 487.63M $4.84B $456.47M $4.09M $4.38B
2021-06-30 $10.32 311.5M $3.21B -$ -$ $3.21B
2021-03-31 $10.08 311.5M $3.14B -$ -$ $3.14B
2020-12-31 $10.08 311.5M $3.14B $489.68M $5.08M $2.66B